Invention Grant
- Patent Title: Quinuclidines for modulating alpha 7 activity
- Patent Title (中): 用于调节α7活性的喹喔啉
-
Application No.: US14794497Application Date: 2015-07-08
-
Publication No.: US09434724B2Publication Date: 2016-09-06
- Inventor: Geoffrey M. Bilcer , Raymond Ng
- Applicant: Alpharmagen, LLC
- Applicant Address: US CA South San Francisco
- Assignee: ALPHARMAGEN, LLC
- Current Assignee: ALPHARMAGEN, LLC
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: C07D453/00
- IPC: C07D453/00 ; C07D209/04 ; A61K31/439 ; C07D453/02 ; A61K45/06
Abstract:
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
Public/Granted literature
- US20160009706A1 QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY Public/Granted day:2016-01-14
Information query
